Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF)

NCT03996772 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03996772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF)
Lead sponsor
Imperial College London
Phase
Phase 3
Overall status
Completed
Start date
June 3, 2019
Completion date
May 31, 2024
Enrollment
319 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, intracerebral hemorrhage